Muravskaia G V, Proleskovskiĭ A K, Karas' A V
Vopr Onkol. 1976;22(6):16-23.
As a result of distance gamma-therapy on Rocus-123 machine in patients with pulmonary cancer in stage II-IV, the survival for a year period and longer was noted in 57.5 +/- 4.5%, over 3 years--in 19.5 +/- 3.6%; over 5 years--in 7.2+/- 2.4%. An average life survival was 21.6 +/- 1.8%.
对II-IV期肺癌患者使用Rocus-123机器进行远距离伽马治疗的结果显示,一年及更长时间的生存率为57.5 +/- 4.5%,超过3年的生存率为19.5 +/- 3.6%;超过5年的生存率为7.2 +/- 2.4%。平均生存时间为21.6 +/- 1.8%。